MENU
MDNAF
Stock ticker: OTC
PRICE
CHANGE
CAPITALIZATION
Medicenna Therapeutics (MDNAF) Ownership - Who owns Medicenna Therapeutics?
Medicenna Therapeutics Corp is a Canada-based immuno-oncology company... Show more
Profile
Industry
N/A
Address
2 Bloor Street W.
Phone
+1 416 648-5555
Employees
16
Web
https://www.medicenna.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
50.65M
P/E Ratio
N/A
Total Cash
30M
Projected Growth
N/A
Total Debt
174K
Revenue
N/A
Risk (Beta)
3.02
Dividend Yield
N/A
Total Cash/Share
0.36
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
Fundamentals
MDNAF
Capitalization
50.7M
P/E Ratio
N/A
Risk (Beta)
3.02
Dividend Yield
N/A
Total Cash
30M
Total Cash/Share
0.36
Total Debt
174K
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
17.5M
P/B Ratio
3.62
Cash Flow
N/A
Earnings
-0.37
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
116M
Current Ratio
10.09
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
-18.65M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-96.91
Shares Held By Institutions
0
Shares Outstanding - Current
83.4M
Total Liabilities
14.8M
Total Volume MTD
N/A
Value
N/A
Gain YTD
-47.598
View a ticker or compare two or three
VS
VS
Show more...
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
2 Bloor Street W.
Phone
+1 416 648-5555
Employees
16
Web
https://www.medicenna.com